All In Biotech

Drug Trial Radar · NCT02910206

Etomidate to Improve Outcome in Elderly Patients

Comparative Effect of Etomidate and Propofol on Major Complications After Abdominal Surgery in Elderly Patients

Last checked: Nov 19, 2026Latest source record: Dec 10, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,917 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,917

Actual

Start

Aug 15, 2017

Primary completion

Nov 20, 2019

Study completion Nov 20, 2020

Sponsor

Lead sponsor
Zhihong LUAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 21, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 65 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Elderly patients have high mortality and postoperative complications rate after surgery, especially postoperative cardiac complications. A meta-analysis revealed haemodynamic intraoperative events significantly increased the risk of postoperative cardiac complications.To limit the risk, optimize the intraoperative management of circulation is essential. Anesthetic drug may effect on the haemodynamic intraoperative, reduction of postoperative complications should aimed at choosing the optimal anesthetic drug with minimal effect on haemodynamic.So this study is to explore the comparative efficacy and safety of anesthetic drug (etomidate or propofol) in elderly patients

Conditions

  • Postoperative Complications

Interventions

  • EtomidateDrug

    etomidate is given intravenously

  • propofolDrug

    propofol is given intravenously

  • SufentanilDrug

    sufentanil is given intravenously

  • CisatracuriumDrug

    Cisatracurium is given intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with complications defined by ICD (International codes of diseases)-9Time frame: From the moment of giving sufentanil to the moment of discharge from hospital,up to 7 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Xijing Hospital, Fourth Military Medical University

    Xi'an, Shaanxi, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.